With the market seemingly at an inflection point, cautious investors can try to hedge via options on the market itself, or by targeting single stocks. More
7 Biotechnology Stocks to Sell Now
For the current week, the overall ratings of seven Biotechnology stocks are worse, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
Sell in April and Go Away?
With sell signals flashing on the midcap and small-cap indices, this may be the right course of action for lower-quality stocks. More
Healthcare Stocks Heat Up — Tuesday’s IP Market Recap
A change in reimbursement rates for Medicare Advantage helped propel healthcare stocks Tuesday. That, coupled with positive economic data, pushed the major indices higher. More
Why Comcast Shouldn’t Fire Stephen Burke
Sure, NBC is a bit of a mess lately. But it's only a small portion of Comcast's enormous business. More
Should You Follow Icahn Into Nuance?
Activist investor Carl Icahn has disclosed a big stake in voice recognition software company Nuance -- an attractive player in a number of mega-trends. More
